You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 63 No. 6, June 2006 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Contribution
 This Article
 •Full text
 •PDF
 •Correction
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (8)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Immunologic Disorders
 •Myasthenia Gravis
 •Neuromuscular diseases
 •Neuro-ophthalmology
 •Neurology, Other
 •Alert me on articles by topic

Neuromyelitis Optica in Patients With Myasthenia Gravis Who Underwent Thymectomy

Ilya Kister, MD; Sandeep Gulati, MD; Cavit Boz, MD; Roberto Bergamaschi, MD; Guiseppe Piccolo, MD; Joel Oger, MD; Michael L. Swerdlow, MD

Arch Neurol. 2006;63:851-856.

Background  Myasthenia gravis (MG) and neuromyelitis optica (NMO, also known as Devic disease) are rare autoimmune disorders, with upper-limit prevalence estimates in the general population of 15 per 100 000 and 5 per 100 000, respectively. To our knowledge, an association between these diseases has not been previously reported.

Objectives  To describe 4 patients with MG who developed NMO after thymectomy and to analyze possible causes of apparent increased prevalence of NMO among patients with MG.

Design  Case series.

Patients  Four patients with MG who underwent thymectomy.

Interventions  None.

Results  The prevalence of MG within the published cohort of patients with NMO is more than 150 times higher than that in the general population.

Conclusion  Dysregulation of B-cell autoimmunity in myasthenia, possibly exacerbated by loss of control over autoreactive cells as a result of thymectomy, may predispose patients to the development of NMO.


Author Affiliations: Departments of Neurology, Albert Einstein College of Medicine, Bronx, NY (Drs Kister and Swerdlow), and Long Island Jewish Medical Center, New Hyde Park, NY (Dr Gulati); Multiple Sclerosis Clinic, University of British Columbia, Vancouver (Drs Boz and Oger); and Multiple Sclerosis Center, Neurological Institute "C. Mondino," Pavia, Italy (Drs Bergamaschi and Piccolo).



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Thymic hyperplasia in a patient with recurrent transverse myelitis with clinical resolution after thymectomy
Hammond et al.
J. Neurol. Neurosurg. Psychiatry 2008;79:334-335.
FULL TEXT  

Neuromyelitis Optica in a Mother and Daughter
Braley and Mikol
Arch Neurol 2007;64:1189-1192.
ABSTRACT | FULL TEXT  

Occurrence of CNS demyelinating disease in patients with myasthenia gravis.
Weinshenker et al.
Neurology 2007;68:1326-1326.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2006 American Medical Association. All Rights Reserved.